Factor 7 (AA 301-400) anticorps (HRP)
Aperçu rapide pour Factor 7 (AA 301-400) anticorps (HRP) (ABIN1414641)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 301-400
-
Réactivité croisée
- Humain
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human Factor VII heavy chain
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Conseil sur la manipulation
- Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- Factor 7
-
Sujet
-
Synonyms: SPCA, Coagulation factor VII, Proconvertin, Serum prothrombin conversion accelerator, F7
Background: Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.
-
ID gène
- 2155
-
UniProt
- P08709
Antigène
-